Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

Conjugation Strategies Across Emerging Therapeutic Modalities

ET
60 Minutes

In this Fierce webinar, ChemPartner expert Philip Clarke, PhD, will highlight advances in next‑generation conjugation across emerging modalities beyond traditional ADCs. The presentation will cover innovations in peptide conjugates, oligonucleotide (ON) targeting, PROTACs and more.

Speakers

placehoder headshot

Phil Clarke, PhD

Phil Clarke, PhD, is an associate director of scientific communications at ChemPartner, where he supports both scientific and commercial teams through troubleshooting, project management of chemistry programs, and the generation of scientific content.
Clarke completed his PhD in synthetic organic chemistry at the University of Southampton in 2003, under the supervision of Bruno Linclau, PhD, focusing on asymmetric Diels–Alder methodology. Prior to joining ChemPartner, he held leadership roles at Concept Life Sciences and Charnwood Discovery, where he managed drug discovery projects, developed high-performing teams, and delivered innovative chemistry solutions across a range of therapeutic areas.

Register here!

Date/Time:
ET